Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
The Journal of Clinical Investigation|June 21, 2005
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancerPunita Dhawan, Amar B Singh, Natasha G Deane, et al.Gut|June 15, 2013
Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signallingJillian L Pope, Ajaz A Bhat, Ashok Sharma, et al.Gut Microbes|November 27, 2023
Loss of claudin-3 expression increases colitis risk by promoting Gut DysbiosisRizwan Ahmad, Balawant Kumar, Ishwor Thapa, et al.Molecular Cancer|August 3, 2018
MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signalingSrijayaprakash Babu Uppada, Saiprasad Gowrikumar, Rizwan Ahmad, et al.Cancers|May 5, 2021
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem CellsBalawant Kumar, Rizwan Ahmad, Swagat Sharma, et al.Oncogene|July 7, 2026
Humanized anti-Claudin-1 antibodies to treat colorectal cancerMark Primeaux, Zeina Nehme, Iram Fatima, et al.Gastroenterology|September 1, 2011
Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cellsAmar B Singh, Ashok Sharma, J Joshua Smith, et al.Journal of Experimental & Clinical Cancer Research : CR|February 24, 2021
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activationBalawant Kumar, Rizwan Ahmad, Giovanna A Giannico, et al.JACC. Basic to Translational Science|May 17, 2021
Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary BypassJeffrey Salomon, Aaron Ericsson, Amber Price, et al.Annals of Gastroenterology|January 2, 2020
Curcumin use in ulcerative colitis: is it ready for prime time? A systematic review and meta-analysis of clinical trialsSaurabh Chandan, Babu P Mohan, Ojasvini C Chandan, et al.Pageof 10